Summit Therapeutics Inc. · NASDAQ:SMMT
Duggan Robert W exercised options for 500,000 Summit Therapeutics Inc. shares (Form 4)
Traded Nov 16, 2026 · Filed Nov 16, 2026
On Nov 16, 2026, Duggan Robert W (Director, Co-Chief Executive Officer, 10% owner) exercised options for 500,000 Summit Therapeutics Inc. shares at US$1.06 for US$530K, leaving 531,000 shares. Filed Nov 16, 2026 (Form 4).
- Options exercised
- 500,000 shares
- Price
- US$1.06
- Value
- US$530K
- Holding after
- 531,000 shares (held indirectly)
- Trading plan
- No
- Role
- Director, Co-Chief Executive Officer, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | Option exercise | 500,000 | US$1.06 | 531,000 | Indirect |
Source
Download original · View original at SEC
Related
- Summit Therapeutics Inc.
- Duggan Robert W
- Summit Therapeutics Inc. shareholders
- Form 4 · Duggan Robert W · Nov 20, 2026
- Form 4 · Duggan Robert W · Jun 12, 2026
- Form 4 · Duggan Robert W · Jun 4, 2026
- Form 4 · Zanganeh Mahkam · Nov 20, 2026
- Form 4 · Soni Manmeet Singh · Nov 16, 2026
- Form 4 · Zanganeh Mahkam · Nov 16, 2026
- Form 4 · Anand Bhaskar · Oct 14, 2026
- Form 4 · Zanganeh Mahkam · Jun 12, 2026